Editorial

Gout Beyond the Urate Number: An Integrated Approach to Recurrent Shoulder Monoarthritis and Renal Microlithiasis

DOI https://doi.org/10.70302/jpsim.v7i4.2657
Received: 11 Aug 2026 Revised: 20 Oct 2026 Accepted: 04 Nov 2026 Published Online: 20 Nov 2026

Abstract

How to Cite This Article

Haroon M, Hussnain SM. Gout Beyond the Urate Number: An Integrated Approach to Recurrent Shoulder Monoarthritis and Renal Microlithiasis. J Pak Soc Intern Med. 2026;7(4):281–283. doi:10.70302/jpsim.v7i4.2657

⭳ Download XML (JATS)

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843-55.
  2. Zhang J, Sun W, Gao F, Lu J, Li K, Xu Y, et al. Changes of serum uric acid level during acute gout flare and related factors. Front Endocrinol (Lausanne). 2023; doi:10.3389/fendo.2023.1077059. doi:10.3389/fendo.2023.1077059
  3. National Institute for Health and Care Excellence. Gout: diagnosis and management. NICE guideline NG219. London: NICE; 2022. Available from: https://www.nice.org.uk/guidance/ng219.
  4. Mandl P, D’Agostino MA, Navarro-Compán V, Geßl I, Sakellariou G, Abhishek A, et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis. 2024;83(6):752-9.
  5. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31-8.
  6. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744-60.
  7. Choi HK, Soriano LC, Zhang Y, Rodríguez LAG. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;doi:10.1136/bmj.d8190. doi:10.1136/bmj.d8190
  8. White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378(13):1200-10.
  9. Mackenzie IS, Ford I, Nuki G, Hallas J, Hawkey CJ, Webster J, et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet. 2020;396(10264):1745-57.
  10. Pearle MS, Matlaga BR, Antonelli JA, Asher GN, Chi T, Hsi RR, et al. Medical Management of Kidney Stones: AUA Guideline (2026) Part I: Evaluation of Patients With Kidney Stones and Dietary Management of Patients With Calcium Stones. J Urol. 2026;216(5):613-22.
  11. Pearle MS, Matlaga BR, Antonelli JA, Chi T, Hsi RR, Kim SK, et al. Medical Management of Kidney Stones: AUA Guideline (2026) Part II: Treatment and Follow-up of Kidney Stones. J Urol. 2026;216(5):623-31.
  12. European Association of Urology. EAU Guidelines on Urolithiasis. Edition presented at the EAU Annual Congress, London 2026. Arnhem: EAU Guidelines Office; 2026. ISBN: 978-94-92671-32-5.
  13. DailyMed. Potassium citrate extended-release tablets: prescribing information [Internet]. Bethesda (MD): National Library of Medicine; revised 2025 [cited 2026 October 19]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6ce81aa-ed9e-4eac-9f9c-26e2560f06db.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2026 The Author(s).